PALO ALTO, Calif.–(BUSINESS WIRE)–TCG Crossover (“TCG X”) is worked up to welcome Simon Basseyn, M.D. to the New York Metropolis based mostly funding crew on the agency.
Previous to becoming a member of TCG X, Simon was a senior analyst at Ghost Tree Capital, a life-sciences centered hedge fund based mostly in New York. He holds an M.D. from the Perelman Faculty of Drugs on the College of Pennsylvania and an M.B.A. in Well being Care Administration from The Wharton Faculty. Simon beforehand accomplished internships in inside medication at Weill Cornell/New York Presbyterian, administration consulting at McKinsey & Firm, and biotech enterprise capital at SR One and presently maintains an lively medical license in New York.
“I’m thrilled to affix the proficient founding funding crew at TCG X and keen to start investing in corporations creating modern science throughout the crossover and public phases,” stated Simon Basseyn.
“We’re excited to welcome Simon as the most recent member of our funding crew. Simon’s robust technical background and various set of working experiences throughout the well being care sector are an ideal match for TCG X,” stated Chen Yu, Founding Managing Accomplice of TCG X.
About TCG X
TCG X is a healthcare funding agency devoted to advancing disruptive medicines and supporting corporations that may enhance the lives of sufferers. TCG X invests in each personal and public corporations led by distinctive entrepreneurs centered on creating higher remedy choices for sufferers. TCG X has funding groups in Palo Alto and New York Metropolis. For extra info, please go to www.TCGcrossover.com.